Trials / Completed
CompletedNCT05946304
Exercise Training in Women With Cardiac Devices
The Effects of Exercise Training on Physical and Mental Health in Women With Cardiac Implantable Electronic Devices (CIED-EX): a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ottawa Heart Institute Research Corporation · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac implantable electronic devices (CIED) are established treatments for a variety of cardiac arrhythmias. Women with CIED have lower fitness and lower quality of life compared to men with CIED. Moderate-intensity continuous training (MICT) is the most prescribed exercise for women. However, high-intensity interval training (HIIT) has been shown to improve fitness, anxiety levels, quality of life, and other health indicators over MICT in men with CIED. There is a need to quantitatively evaluate the feasibility and effects of a virtual HIIT vs. virtual MICT program on the physical, quality of life, and mental health of women with CIED. Furthermore, a qualitative approach is also necessary to understand patients' experiences, barriers, and facilitators of a virtual exercise intervention. This mixed-methods pilot randomized controlled trial will assess the feasibility of a 12-week virtual HIIT and MICT program in women with CIED.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | moderate-intensity continuous exercise training (MICT) group | Exercise session: Warm-up: 60-70% peak heart rate (HR) - 10min; Training: 70-85% peak HR - 35min; Cool-down: 60-70% peak HR - 15min. |
| BEHAVIORAL | high-intensity interval training (HIIT) group | Warm-up: 60-70% peak heart rate (HR) - 10min; Training: 85-95% peak HR - 25 minutes (4x4-minutes of high-intensity intervals interspersed with 3 minutes of low-intensity intervals); Cool-down: 60-70% peak HR - 10min. |
Timeline
- Start date
- 2023-11-28
- Primary completion
- 2025-08-18
- Completion
- 2025-08-18
- First posted
- 2023-07-14
- Last updated
- 2026-03-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05946304. Inclusion in this directory is not an endorsement.